Repligen
RGEN
#2045
Rank
โ‚น834.85 B
Marketcap
โ‚น14,831
Share price
-0.47%
Change (1 day)
23.11%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น262.82 Billion

According to Repligen 's latest financial reports the company's total assets are โ‚น262.82 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น242.74 B2.99%
2023-12-31โ‚น235.69 B12.51%
2022-12-31โ‚น209.49 B19.34%
2021-12-31โ‚น175.53 B26.13%
2020-12-31โ‚น139.16 B39.38%
2019-12-31โ‚น99.84 B84.34%
2018-12-31โ‚น54.16 B14.09%
2017-12-31โ‚น47.47 B141.81%
2016-12-31โ‚น19.63 B102.02%
2015-12-31โ‚น9.71 B19.52%
2014-12-31โ‚น8.13 B10.93%
2013-12-31โ‚น7.32 B38%
2012-12-31โ‚น5.31 B
2011-03-31โ‚น3.21 B0.88%
2010-03-31โ‚น3.18 B-14.55%
2009-03-31โ‚น3.72 B35.13%
2008-03-31โ‚น2.75 B119.76%
2007-03-31โ‚น1.25 B-2.1%
2006-03-31โ‚น1.28 B6.79%
2005-03-31โ‚น1.20 B-6.53%
2004-03-31โ‚น1.28 B0.8%
2003-03-31โ‚น1.27 B-10.33%
2002-03-31โ‚น1.42 B-5.23%
2001-03-31โ‚น1.49 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
โ‚น106.06 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น684.54 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น383.46 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น11.528 T 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น9.261 T 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.709 T 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.764 T 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น227.09 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น7.96 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น675.46 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA